Credo Technology insider sale: 80,000 shares via 10b5-1

Rhea-AI Filing Summary

Credo Technology Group (CRDO) reported insider activity: a director and Chief Operating Officer sold 80,000 ordinary shares on 10/01/2025 in multiple trades under a Rule 10b5-1 trading plan adopted on July 2, 2025.

The sales were executed at weighted average prices between $141.6018 and $145.1814, with trade ranges from $141.01 to $145.60. Following these transactions, the reporting person beneficially owned 920,000 shares indirectly via Zhan BVI Co Ltd, 125,000 shares indirectly via EZ Trust, and 2,628,403 shares directly. The filing notes that indirect holdings are disclaimed except to the extent of any pecuniary interest.

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

X

Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.

1. Name and Address of Reporting Person^*

Lam Yat Tung

(Last) (First) (Middle)

110 RIO ROBLES

(Street)

SAN JOSE CA 95134

(City) (State) (Zip)

2. Issuer Name and Ticker or Trading Symbol
Credo Technology Group Holding Ltd [ CRDO ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

X	Director		10% Owner
X	Officer (give title below)		Other (specify below)
	Chief Operating Officer

3. Date of Earliest Transaction (Month/Day/Year)
10/01/2025

4. If Amendment, Date of Original Filed (Month/Day/Year)

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
			Code	V	Amount	(A) or (D)	Price
Ordinary Shares	10/01/2025		S(1)		4,700	D	$141.6018(2)	995,300	I	By Zhan BVI Co Ltd(3)
Ordinary Shares	10/01/2025		S(1)		19,233	D	$142.7065(4)	976,067	I	By Zhan BVI Co Ltd(3)
Ordinary Shares	10/01/2025		S(1)		31,197	D	$143.5223(5)	944,870	I	By Zhan BVI Co Ltd(3)
Ordinary Shares	10/01/2025		S(1)		22,256	D	$144.4823(6)	922,614	I	By Zhan BVI Co Ltd(3)
Ordinary Shares	10/01/2025		S(1)		2,614	D	$145.1814(7)	920,000	I	By Zhan BVI Co Ltd(3)
Ordinary Shares								125,000	I	By EZ Trust(8)
Ordinary Shares								2,628,403	D

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
				Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares

Explanation of Responses:

1. The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on July 2, 2025.

2. This transaction was executed in multiple trades at prices ranging from $141.01 to $141.98. The price reported above reflects the weighted average sale price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.

3. The Reporting Person disclaims beneficial ownership of these indirectly held shares except to the extent of any pecuniary interest therein.

4. This transaction was executed in multiple trades at prices ranging from $142.03 to $143.02. The price reported above reflects the weighted average sale price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.

5. This transaction was executed in multiple trades at prices ranging from $143.03 to $144.02. The price reported above reflects the weighted average sale price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.

6. This transaction was executed in multiple trades at prices ranging from $144.03 to $145.02. The price reported above reflects the weighted average sale price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.

7. This transaction was executed in multiple trades at prices ranging from $145.03 to $145.60. The price reported above reflects the weighted average sale price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.

8. The Reporting Person disclaims beneficial ownership except to the extent of his spouse's pecuniary interest therein.

Remarks:

	/s/ James Laufman, attorney-in-fact	10/03/2025
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.

FAQ

What insider transaction did CRDO report on Form 4?

A director and Chief Operating Officer sold 80,000 ordinary shares on 10/01/2025 via multiple trades.

Was the CRDO insider sale under a Rule 10b5-1 plan?

Yes. The sales were made pursuant to a Rule 10b5-1 plan adopted on July 2, 2025.

At what prices were the CRDO shares sold?

Weighted averages ranged from $141.6018 to $145.1814, with trade ranges from $141.01 to $145.60.

How many CRDO shares does the insider own after the transactions?

Beneficial ownership includes 920,000 shares indirectly via Zhan BVI Co Ltd, 125,000 indirectly via EZ Trust, and 2,628,403 directly.

What roles does the reporting person hold at CRDO?

The reporting person is a Director and Chief Operating Officer.

Does the insider disclaim beneficial ownership of indirect holdings?

Yes. Indirect holdings are disclaimed except to the extent of any pecuniary interest.